BUZZ-Australia's Nova Eye Medical jumps to 8-month high on NMPA approval
Reuters
Sep 30, 2025
BUZZ-Australia's Nova Eye Medical jumps to 8-month high on NMPA approval
** Shares of Australia's Nova Eye Medical EYE.AX rise as much as 16.6% to A$0.170; their highest since January 28
** Ophthalmic treatment technologies firm says China's NMPA approved the registration of iTrack Advance, a glaucoma surgical device, in the Asian country
** Nearly 1.2 million shares change hands, around 4.1x 30-day average; co's busiest day since August 19
** Including session's moves, EYE up 6.3% YTD
(Reporting by Keshav Singh Chundawat in Bengaluru)
((Keshav.singhchundawat@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.